NT-ProBNP in AL amyloidosis: changes after chemotherapy and association with survival

被引：0
作者：
Wechalekar, A. D. [1 ]
Lachmann, H. J. [1 ]
Gillmore, J. D. [1 ]
Offer, M. [1 ]
Joshi, J. J. [1 ]
Hawkins, P. N. [1 ]
机构：
[1] UCL, Natl Amyloidosis Ctr, London, England
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [31] A Longitudinal Analysis of NT-proBNP After LVAD Implantation
    Falls, C.
    Lolay, G.
    Kido, K.
    George, B.
    Omar, H.
    Guglin, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04) : S346 - S347
  • [32] Correlation to NT-ProBNP and Remodeling after Cardiac Surgery
    Napchan Boer, Berta Paula
    Campos Vieira, Marcelo Luiz
    Sampaio, Roney Orismar
    Abensur, Henry
    de Oliveira, Alessandra Gomes
    Fernandes, Joao Ricardo
    Grinberg, Max
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2013, 100 (05) : 469 - 475
  • [33] Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design
    Vaxman, I.
    Kumar, S. K.
    Buadi, F.
    Lacy, M. Q.
    Dingli, D.
    Hwa, Y.
    Fonder, A.
    Hobbs, M.
    Hayman, S.
    Kourelis, T.
    Warsame, R.
    Muchtar, E.
    Leung, N.
    Kapoor, P.
    Grogan, M.
    Go, R.
    Lin, Y.
    Gonsalves, W.
    Siddiqui, M.
    Kyle, R. A.
    Rajkumar, S. V.
    Gertz, M. A.
    Dispenzieri, A.
    LEUKEMIA, 2021, 35 (12) : 3604 - 3607
  • [34] Abnormal NT-ProBNP in AL amyloidosis patients without cardiac involvement at diagnosis -: A predictor of subsequent cardiac involvement
    Wechalekar, Ashutosh D.
    Lachmann, Helen J.
    Gillmore, Julian D.
    Hawkins, Philip N.
    BLOOD, 2007, 110 (11) : 449A - 449A
  • [35] The association of plasma NT-proBNP level and progression of diabetic nephropathy
    Zhao, Y.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [36] Changes in NT-proBNP in Young Children With Congenital Heart Malformations
    Butnariu, Angela
    Iancu, Mihaela
    Samasca, Gabriel
    Chira, Manuel
    Lupan, Iulia
    LABMEDICINE, 2014, 45 (01): : 43 - 47
  • [37] Early changes in left ventricular diastolic function after chemotherapy predict subsequent NT-proBNP elevation in breast cancer patients
    Andreia Magalhaes, A.
    Menezes, M.
    Saraiva, M.
    Cortez-Dias, N.
    Santos, L.
    Silva, D.
    Costa, P.
    Costa, A. L.
    Costa, L.
    Fiuza, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 72 - 72
  • [38] NT-proBNP levels and QT changes in acute ischemic stroke
    Acikalin, Ayca
    Satar, Salim
    Akpinar, Onur
    Cagliyan, Caglar Emre
    Sahan, Mustafa
    Icme, Ferhat
    Gulen, Muge
    Yildiz, Mehmet
    NEUROLOGY ASIA, 2013, 18 (01) : 1 - 8
  • [39] DETECTION OF CARDIAC AMYLOIDOSIS IN PATIENTS WITH SYSTEMIC AL AND ATTR AMYLOIDOSIS USING IODINE EVUZAMITIDE PET/CT IMAGING AND THE CORRELATION WITH SERUM NT-PROBNP
    Wall, Jonathan
    Heidel, R. Eric
    Martin, Emily B.
    Stuckey, Alan
    Powell, Dustin
    Guthrie, Spencer
    Lands, Ronald
    Kennel, Stephen J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1184 - 1184
  • [40] Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis
    G Merlini
    I Lousada
    Y Ando
    A Dispenzieri
    M A Gertz
    M Grogan
    M S Maurer
    V Sanchorawala
    A Wechalekar
    G Palladini
    R L Comenzo
    Leukemia, 2016, 30 : 1979 - 1986
12345